Content

Screening 80 neuroendocrine lung cancer patients by using NanoString Technology implies several targets for new tailored therapies

Robert Fred Henry Walter, Fabian Dominik Mairinger, Robert Werner, Saskia Ting, Claudia Vollbrecht, Dirk Theegarten, Georgis Stamatis, Denise Zwanziger, Wilfried Eberhardt, Martin Schuler, Daniel Christian Christoph, Lutz Freitag, Kurt Werner Schmid, Jeremias Wohlschläger: Screening 80 neuroendocrine lung cancer patients by using NanoString Technology implies several targets for new tailored therapies. Jahrestagung der deutschen Gesellschaft für Pathologie e. V.